PSTV

#4003
PLUS THERAPEUTICS, Inc. - Common Stock
5.8 2 USD
-9.49%
Setor: Cuidados de saúde
Base: USD
Moeda do lucro: USD
Faixa diária
5.82
5.82
Faixa anual
0.13
8.00
Mudança diária
-9.49%
Mudança mensal
+4.49%
Mudança em 6 meses
+854.10%
Mudança anual
+1906.90%
Fechamento anterior
6.4 3
Open
5.8 2
Mínimo
5.8 2
High
5.8 2
Volume
22
Abrir gráfico completo Full chart

Financials

Visão geral Relatórios Estatísticas
Trimestral Ano
Demonstração de resultados Balanço patrimonial Fluxo de caixa
Valor 202020212022202320242025 TTM

PLUS THERAPEUTICS, Inc. - Common Stock

Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company headquartered in Houston, Texas, that develops targeted radiotherapeutics and diagnostic services for brain and central nervous system cancers. The company’s lead therapeutic candidate, marketed as REYOBIQ™, is an investigational liposomal radiopharmaceutical under clinical evaluation for recurrent glioblastoma, leptomeningeal metastases, and certain pediatric brain cancers. Plus Therapeutics also commercialized a molecular diagnostic service, CNSide®.

Notícias